Category: Our current thinking


IDMP+ Status Reflections

November 18, 2016 | 0 Comments

Time to consider and act: A newly extended “Regulatory Grace Period”
IDMP Status Reflections update

July 9, 2015 | 0 Comments

ISO IDMP is coming – proposed now as an EMA phased approach – but we are not there yet, with EC to approve: Worth reading!
IDMP Status Reflections update

June 11, 2015 | 0 Comments

Time to share Reflections: With all these standards the question comes up: How does a company want to apply them? What is it’s business ambition?
IDMP Status Reflections

February 17, 2015 | 0 Comments

Though many points remain open, we have at least some indications about how the European Agency intends to proceed:
BI in Healthcare

February 7, 2015 | 0 Comments

Business Intelligence (BI) and Analytics for Healthcare (HC), considering the impact of Social Media: Source for BioPharma R&D & Business Development
IDMP Status Reflections

February 1, 2015 | 0 Comments

The application of ISO IDMP Standards will bring you to an important level of Regulated, Actionable Quality Information for you internally and with your key Stakeholders – globally Since the Vioxx scandal and the product recall in 2004 the urgent need for patient safety reached the highest levels of awareness and the requirement to harmonize data globally to take effective and timely actions.